Search for: "MERRELL v. U.S."
Results 321 - 340
of 382
Sorted by Relevance
|
Sort by Date
18 Sep 2019, 10:02 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
28 Apr 2019, 9:06 pm
Merrell Dow Pharmaceuticals, the U.S. [read post]
15 Dec 2009, 1:56 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993)]). [read post]
17 Oct 2015, 5:29 am
” Earp v. [read post]
22 Dec 2009, 8:57 pm
John Deere Co., 383 U.S. 1, 17 (1966); Kinetic Concepts, 554 F.3d at 1019. [read post]
24 Jun 2015, 7:27 pm
DePyper v. [read post]
9 Jun 2015, 5:54 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), and (3) the testimony assists the trier of fact through the application of scientific, technical, or other specialized expertise. [read post]
7 Mar 2010, 12:47 pm
Merrell Dow Pharms., Inc., 509 U.S. 579, 589 (1993). [read post]
18 Oct 2019, 10:02 am
Merrell Dow Pharms. and the Texas Supreme Court in E.I. du Pont de Nemours v. [read post]
24 Mar 2017, 8:00 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
14 May 2012, 8:24 am
Joiner, 522 U.S. 136 (1997)(questioning the external validity of a study of massive injected doses of PCBs in baby mice, with an outcome unrelated to the cancer claimed by paintiff) 1st Circuit Sutera v. [read post]
4 Aug 2012, 9:14 am
Casey, 505 U.S. 833, 882-83 (1992). [read post]
4 Jan 2011, 4:08 pm
Merrell Dow Pharm., Inc., 509 U.S. 589 (1993)). [read post]
11 May 2020, 1:09 am
In the face of this traditional judicial lassitude, “[v]igorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof” were all a litigant could hope to accomplish in litigation. [read post]
19 Jul 2012, 4:07 pm
Colo. 2006), rev’d and remanded on other grounds, 618 F.3d 1127 (10th Cir. 2010), cert. denied, ___ U.S. ___ (May 24, 2012); Flebotte v. [read post]
4 Oct 2021, 8:17 am
Merrell Dow Pharms., Inc., 509 U.S. 579,587 (1993). [3] Frye v. [read post]
2 Jun 2020, 12:54 am
Co. v. [read post]
20 Sep 2009, 11:07 pm
Merrell Dow Pharms., 509 U.S. 579, 591 (1993) (holding that evidence is relevant if it may assist the trier of fact in resolving a factual dispute); Moleculon, 793 F.2d at 1272. [read post]
17 Jun 2021, 12:29 pm
He then found that what remained, if anything, could not reasonably support a verdict for plaintiffs, and he entered summary judgment for the defense in the opt-out cases.[6] In 1993, the U.S. [read post]
4 Oct 2019, 4:38 pm
This reframing crisply captures the dynamic Bruhl noted in U.S. v. [read post]
